康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688185 康希诺

已收盘 09-30 15:00:00

{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":102.64,"timestamp":1790751600000,"preClose":85.53,"halted":0,"volume":10661744,"delay":0,"changeRate":0.2,"floatShares":113999999,"shares":247000000,"eps":0.1645,"marketStatus":"已收盘","change":17.11,"latestTime":"09-30 15:00:00","open":86.44,"high":102.64,"low":85.67,"amount":1065000000,"amplitude":0.1984,"askPrice":0,"askSize":0,"bidPrice":102.64,"bidSize":17729,"shortable":0,"etf":0,"ttmEps":0.1645,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":85.53,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":94.08,"lowLimit":76.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247043801,"isCdr":false,"pbRate":5.09,"roa":"--","peRate":623.951368,"roe":"--","epsLYR":0.11,"committee":0,"marketValue":25357000000,"turnoverRate":0.0932,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","afterMarket":{"amount":20528,"volume":200,"close":102.64,"buyVolume":56184,"sellVolume":0,"time":1790753637746,"indexStatus":"已收盘 09-30 15:30:00","preClose":85.53},"hkstockBrief":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":36.54,"timestamp":1790755707007,"preClose":31.1,"halted":0,"volume":20603303,"delay":0,"premium":"-69.52"},"floatMarketCap":11739000000},"requestUrl":"/m/hq/s/688185","defaultTab":"news","newsList":[{"id":"2671678361","title":"今日涨停！688185回应mRNA热点：胶质母细胞瘤等肿瘤疫苗仍在早期研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671678361","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671678361?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:45","pubTimestamp":1790779500,"startTime":"0","endTime":"0","summary":"9月30日，康希诺(SH688185)涨停，当日收盘价达102.64元/股，市值254亿元。当日晚间，康希诺公告称，公司股票于2026年9月28日、9月29日及9月30日连续三个交易日内日收盘价格涨幅偏离值累计超 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260930/c680424439.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260930/c680424439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688185","BK0239","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205420","title":"康希诺最新公告：正在进行mRNA预防用疫苗及治疗性生物制品的开发以及相关递送系统的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671205420?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:51","pubTimestamp":1790765462,"startTime":"0","endTime":"0","summary":"康希诺(688185.SH)发布股票交易异常波动公告，公司关注到近期市场上关于mRNA技术的发展，海外mRNA肿瘤疫苗临床阶段性数据发布或计划公开。mRNA平台是公司布局的技术平台之一，公司正在进行mRNA预防用疫苗及治疗性生物制品的开发，以及相关递送系统的开发。治疗领域方面，公司正在推进mRNA疫苗用于治疗胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发工作，以及InVivoCAR相关疗法的开发，目前均处于早期阶段。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000031654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671057522","title":"创新药一路狂涨！688185，直线20cm涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2671057522","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671057522?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:23","pubTimestamp":1790763780,"startTime":"0","endTime":"0","summary":"9日最后一个交易日，A股三大指数今日涨跌不一，截至收盘，上证指数涨0.31%，深证成指跌0.11%，创业板指跌0.23%，北证50涨0.7%，科创50指数跌2.51%。全市场成交额14500亿元，较上日放量285亿元，全市场超2800只个股下跌。创新药板块涨幅第一，康希诺触及20cm涨停，贝瑞基因、康辰药业、昭衍新药、奥赛康等多股涨停，三元基因、义翘神州涨超10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK1574","BK1161","688185","159992","BK0239","IBBQ","06978","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222053","title":"港股午评|恒生指数早盘跌0.04%    CRO概念股涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222053","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671222053?lang=zh_cn&edition=full","pubTime":"2026-09-30 12:00","pubTimestamp":1790740842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数跌0.04%，跌10个点，报24513点；恒生科技指数跌0.15%。港股早盘成交887亿港元。mRNA概念股涨幅居前。CRO概念股涨幅居前，BD高增叠加湿实验需求升温，行业景气度上行信号明确。泰格医药涨超4%，与迪安诊断签署战略合作协议，将围绕AI制药等多领域开展深度合作。地产港股盘中V型反转，万科企业一度跌超11%，午盘涨超2%。汇量科技涨超8%，AI Infra升级有望进一步提升算法效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1137","BK1507","06127","03033","LU0140636845.USD","03115","MRNA","BK1555","83115","01164","BK1191","LU1188198961.HKD","03088","03347","06185","BK4551","03423","LU1831875114.USD","BK1161","02800","03419","01860","603127","09088","BK1178","MRNY","00625","03032","06802","HSTECH","BK1524","07500","HHImain","BK1206","09067","MCHmain","BK1544","BK4588","600547","06821","WDNA","GNOM","LU0828237940.HKD","BK4585","513600","MRNX","03037","02837","01787","URNJ","01548","LU0244354667.USD","BK1590","07200","02833","BK1141","07552","BK1594","HK0000306685.HKD","300347","LGHT","LU0463099449.HKD","BK1576","BK4533","03067","BK1515","07300","688185","BK1586","BK1583","BK4532","BK1198","BK1240","BK4548","IE0034224299.USD","002821","BK4501","IDNA","BK1574","02362","HK0000320223.HKD","BK1613","HSI","02723","03417","82800","HK0000306701.USD","BK4139","BK1592","LU0326950275.SGD","BK1521","BK4568","000002","07226","BK4534","HK0000320264.USD","BK1518","09115","02202","LU0181495838.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671225002","title":"A股午评：沪指早间涨0.27%，超2300只个股上涨，房地产股探底回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2671225002","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671225002?lang=zh_cn&edition=full","pubTime":"2026-09-30 11:35","pubTimestamp":1790739354,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0273","LU0501845795.SGD","BK0184","600663","BK0053","06185","LU0067412154.USD","LU1807302812.USD","BK0196","BK0278","03147","07234","BK0020","BK0201","LU1993786604.SGD","LU1781817850.SGD","BK0187","688185","BK0188","LU0880133367.SGD","IE00B0JY6N72.USD","399006","BK0028","LU0072913022.USD","BK0239","LU1226287529.USD","000001","BK0011","BK0012","BK0183","LU1655091616.SGD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224919","title":"康希诺盘中涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224919","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671224919?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:15","pubTimestamp":1790734500,"startTime":"0","endTime":"0","summary":"9月30日盘中科创板股康希诺涨停，截至09:38，股价报102.64元，成交5.77亿元，换手率5.16%，振幅19.84%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887514985.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887514985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["688185","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671266951","title":"康希诺生物（688185）9月28日主力资金净买入6635.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671266951?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:17","pubTimestamp":1790641025,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，康希诺生物报收于86.5元，上涨5.99%，换手率9.1%，成交量10.4万手，成交额8.9亿元。近5日资金流向一览见下表：康希诺生物融资融券信息显示，融资方面，当日融资买入8488.95万元，融资偿还7080.37万元，融资净买入1408.58万元。康希诺生物主营业务：创新疫苗的研发、生产及商业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900006987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","BK1515","BK0239","BK1191","06185","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670494419","title":"康希诺生物（688185）9月24日主力资金净卖出1.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670494419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670494419?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:29","pubTimestamp":1790296173,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，康希诺生物报收于81.61元，下跌4.27%，换手率8.81%，成交量10.08万手，成交额8.35亿元。近5日资金流向一览见下表：康希诺生物融资融券信息显示，融资方面，当日融资买入6225.43万元，融资偿还8899.21万元，融资净偿还2673.78万元。康希诺生物主营业务：创新疫苗的研发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500005227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06185","BK1515","BK1161","688185","BK1191","BK0239","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669519691","title":"康希诺：公司拥有合作品种商业化后的大中华区权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2669519691","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669519691?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:12","pubTimestamp":1789981935,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺生物09月21日在投资者关系平台上答复投资者关心的问题。此外，康希诺在大中华区拥有的OCU400权益，是否已经覆盖目前Phase 3所涉及的广泛RP人群及相应适应症范围？康希诺生物回复：尊敬的投资人您好，公司已完成该合作候选药物的美国BLA申报前开发工作及PPQ工艺验证，BLA现场检查的相关准备工作正在进行中，公司拥有合作品种商业化后的大中华区权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668164951","title":"康希诺扣非连亏4年半 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2668164951","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668164951?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:35","pubTimestamp":1789626902,"startTime":"0","endTime":"0","summary":"中国经济网北京9月17日讯 康希诺 近日披露2026年半年度报告。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票募集资金总额为52.01亿元，扣除发行费用后，募集资金净额为49.79亿元。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260917/32372917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1146622755.USD","BK0188","LU2148510915.USD","LU1255011170.USD","LU2580892862.HKD","LU0405327494.USD","LU1794554557.SGD","06030","LU2289578879.USD","BK0028","LU2580892789.USD","BK1564","600030","LU1064130708.USD","BK1521","LU1997244956.HKD","LU1997245177.USD","LU1328615791.USD","BK0183","BK0012","688185","LU1064131003.USD","BK0276","BK1147","LU1720050803.USD","IPOS","BK0196","BK1516","LU1997245094.SGD","LU2495084118.USD","LU1820825898.SGD","LU0405327148.USD","LU1655091616.SGD","BK0239","LU1781817850.SGD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667985393","title":"康希诺：关于向2025年A股限制性股票激励计划激励对象授予部分预留限制性股票的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985393","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667985393?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:39","pubTimestamp":1789562340,"startTime":"0","endTime":"0","summary":"    证券日报网讯 9月16日，康希诺发布公告称，公司于2026年9月16日根据2025年第一次临时股东大会授权召开第三届董事会第五次临时会议，审议通过相关议案，以41.2 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260916/c679982678.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260916/c679982678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02827","399300","02846","159982","BK1147","82846","03188","83130","83188","07233","03130","688185","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583218","title":"破发股康希诺跌3.75% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583218","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666583218?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:54","pubTimestamp":1788940444,"startTime":"0","endTime":"0","summary":"中国经济网北京9月9日讯 康希诺 今日收报68.82元，跌幅3.75%。该股目前处于破发状态。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260909/32364702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0012","BK0196","BK0276","LU1064130708.USD","06030","LU1064131003.USD","LU1997245177.USD","LU1328615791.USD","LU1997244956.HKD","LU0405327148.USD","BK0239","LU1255011170.USD","LU2495084118.USD","LU1820825898.SGD","LU1794554557.SGD","LU1720050803.USD","LU1655091616.SGD","BK1516","688185","BK1147","LU2580892862.HKD","IPOS","LU1781817850.SGD","BK1564","BK0183","600030","BK0188","LU1146622755.USD","LU2289578879.USD","LU2580892789.USD","BK1521","LU1580142542.USD","LU0405327494.USD","LU2148510915.USD","LU1997245094.SGD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665336538","title":"每周股票复盘：康希诺（688185）H股/A股股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2665336538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665336538?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:14","pubTimestamp":1788628452,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：康希诺H股和A股的已发行股份及注册资本本月无变动公司公告汇总：H股类别满足港交所公众持股量要求公司公告汇总：2025年A股限制性股票激励计划涉及2,054,600股，本月未新增发行公司公告汇总康希诺生物股份公司截至2026年8月31日的证券变动月报表显示，公司H股和A股的法定注册资本、已发行股份及库存股份数目均无变动。另有2025年A股限制性股票激励计划，涉及2,054,600股限制性股票，本月未新增发行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03188","03130","399300","83130","82846","159982","02827","BK1147","BK0239","07233","688185","02846","83188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380700","title":"破发股康希诺跌6.76% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380700","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664380700?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:46","pubTimestamp":1788511569,"startTime":"0","endTime":"0","summary":"中国经济网北京9月4日讯 康希诺 今日收报68.93元，跌幅6.76%。该股目前处于破发状态。　　康希诺于2020年8月13日在上交所科创板上市，发行数量为2480万股，发行价格209.71元/股，保荐机构为中信证券，保荐代表人为焦延延、马可；联席主承销商为中金公司，副主承销商为渤海证券。　　康希诺首次公开发行股票发行费用为2.21亿元，其中，保荐及承销费用2.05亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260904/32360411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0196","LU1997244956.HKD","LU1997245177.USD","BK0276","688185","LU1580142542.USD","LU2580892789.USD","BK1516","BK0183","BK0239","BK1147","BK0028","LU1146622755.USD","LU1820825898.SGD","LU1794554557.SGD","BK0188","06030","LU1255011170.USD","LU0405327148.USD","LU0405327494.USD","LU2495084118.USD","BK1564","LU1655091616.SGD","LU2580892862.HKD","LU1997245094.SGD","LU1064131003.USD","LU1720050803.USD","LU2148510915.USD","600030","IPOS","LU1781817850.SGD","LU1328615791.USD","LU2289578879.USD","LU1064130708.USD","BK0012","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664500870","title":"康希诺（688185）披露截至2026年8月31日证券变动月报表，9月3日股价上涨2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664500870","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664500870?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:05","pubTimestamp":1788444326,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，康希诺报收于73.93元，较前一交易日上涨2.33%，最新总市值为182.64亿元。近日，康希诺生物股份公司披露截至2026年8月31日的证券变动月报表。H股总数为132,670,900股，A股总数为114,372,901股，总注册资本为人民币247,043,801元。股份期权方面，2025年核心管理层H股购股权计划项下共有860,000份期权，本月无行使情况。另有2025年A股限制性股票激励计划，涉及2,054,600股限制性股票，本月未新增发行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300042148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","161027","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662906638","title":"康希诺(688185)6月30日股东户数1.6万户，较上期减少2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662906638","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662906638?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:41","pubTimestamp":1787910068,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康希诺披露，截至2026年6月30日公司股东户数为1.6万户，较4月30日减少492.0户，减幅为2.99%。在生物制品行业个股中，康希诺股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.54万户。从股价来看，2026年4月30日至2026年6月30日，康希诺区间跌幅为17.1%，在此期间股东户数减少492.0户，减幅为2.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808773","title":"图解康希诺中报：第二季度单季净利润同比增长2146.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808773","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662808773?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:49","pubTimestamp":1787856566,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺2026年中报显示，上半年度公司主营收入5.5亿元，同比上升43.81%；归母净利润-72.08万元，同比上升94.65%；扣非净利润-5004.86万元，同比上升41.74%；其中2026年第二季度，公司单季度主营收入3.6亿元，同比上升46.65%；单季度归母净利润3970.34万元，同比上升2146.59%；单季度扣非净利润506.65万元，同比上升116.52%；负债率27.07%，投资收益870.16万元，财务费用2149.93万元，毛利率76.86%。财报数据概要请见下图:本文数据来源于康希诺2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704615","title":"康希诺最新公告：2026年半年度净亏损72.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662704615?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:31","pubTimestamp":1787830303,"startTime":"0","endTime":"0","summary":"康希诺(688185.SH)发布2026年半年度报告，实现营业收入5.5亿元，同比增长43.81%；归属于上市公司股东的净利润为亏损72.08万元。注：公司Q2净利润0.4亿，Q1净利润-0.4亿，据此计算，Q2净利润环比扭亏为盈。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700046253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164735701","title":"康希诺生物上半年净亏损72.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164735701","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164735701?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:18","pubTimestamp":1787829519,"startTime":"0","endTime":"0","summary":"8月27日（路透社）——康希诺生物股份有限公司（688185.SS）公告，2026年上半年净亏损为720,837元人民币（约合107,259.43美元）。\n（路透投资者简报；邮箱：reutersinvestor.briefs@thomsonreuters.com）\n资料来源日期/时间：2026年8月27日11:01:59 GMT","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706617","title":"康希诺：拟使用不超2.80亿元暂时闲置募集资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706617","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662706617?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:23","pubTimestamp":1787826217,"startTime":"0","endTime":"0","summary":"康希诺：拟使用不超2.80亿元暂时闲置募集资金进行现金管理","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608273856577870.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608273856577870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IQMM","BK0239","688185","MMKT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790863277927,"stockEarnings":[{"period":"1week","weight":0.204},{"period":"1month","weight":0.3611},{"period":"3month","weight":0.9595},{"period":"6month","weight":0.5319},{"period":"1year","weight":0.2907},{"period":"ytd","weight":0.6331}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康希诺生物股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15985人(较上一季度减少2.99%)","perCapita":"7155股","listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","registeredCapital":"24704万元","survey":"　　康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司的主要产品是脑膜炎球菌结合疫苗、肺炎球菌结合疫苗、组分百白破疫苗、重组脊髓灰质炎疫苗等。公司已被国家工业和信息化部评为专精特新“小巨人”企业，入选天津市猎豹企业。公司自主研发的“多糖蛋白结合疫苗关键技术及产业化”项目荣获天津市科学技术进步一等奖。获奖项目所攻克的核心为多糖蛋白结合技术，是当前全球领先的疫苗技术之一。","listedPrice":209.71},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}